Liposomal Bupivacaine Versus Interscalene Nerve Block

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 5, 2019

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Pain, Postoperative
Interventions
DRUG

Exparel

Patients will receive a local injection of liposomal bupivacaine near the end of their shoulder arthroplasty operation.

PROCEDURE

Interscalene Nerve Block

Patients will undergo a pre-operative interscalene nerve block performed by the anesthesiology team.

Trial Locations (1)

45267

University of Cincinnati Medical Center, Cincinnati

All Listed Sponsors
lead

University of Cincinnati

OTHER

NCT03929146 - Liposomal Bupivacaine Versus Interscalene Nerve Block | Biotech Hunter | Biotech Hunter